Karla Acevedo
Acute Care · El Paso, TXNPI 1306576533
Payments from drug & device makers
Across 78 payments — averaging $22.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$399
- GSK$305
- Novo Nordisk$137
- Grifols USA, LLC$107
- AbbVie$104
- Novartis$78
- plus $593 from 16 others
What the payments were for
- Food & beverage$1,722100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 15 | $399 |
| GSK | 18 | $305 |
| Novo Nordisk | 2 | $137 |
| Grifols USA, LLC | 6 | $107 |
| AbbVie | 5 | $104 |
| Novartis | 4 | $78 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Lilly USA, LLC | 3 | $57 |
| Mylan Specialty L.p. | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $48 |
| Sanofi | 2 | $48 |
| Biogen | 2 | $48 |
| Shield Therapeutics Inc | 2 | $46 |
| Boehringer Ingelheim | 2 | $46 |
| Bayer | 2 | $39 |
| Actelion Pharmaceuticals US, Inc. | 1 | $27 |
| Amgen | 1 | $26 |
| Johnson & Johnson | 1 | $19 |
| Baxter Healthcare | 1 | $19 |
| Inogen, Inc. | 2 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,722 in reported general payments places this provider in the 80th percentile of 2,323 acute care providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 36 | $43,422 |
| JardianceEmpagliflozin | 33 | $41,423 |
| OzempicSemaglutide | 28 | $26,048 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 22 | $20,474 |
| EliquisApixaban | 14 | $19,997 |
| JanuviaSitagliptin Phosphate | 11 | $17,462 |
| FarxigaDapagliflozin Propanediol | 11 | $15,633 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $6,151 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $5,221 |
| Omega-3 Acid Ethyl Esters | 22 | $2,236 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 110 | $2,041 |
| Naproxen | 17 | $1,965 |
| Gabapentin | 98 | $1,944 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $1,819 |
| SynthroidLevothyroxine Sodium | 15 | $1,379 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $57 | $43,42236 claims |
| Boehringer IngelheimJardiance | $46 | $41,42333 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $305 | $26,62434 claims |
| Novo NordiskOzempic | $137 | $26,04828 claims |
| AstraZenecaFarxiga, Symbicort | $399 | $20,85425 claims |
| AbbVieSynthroid | $104 | $1,37915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,323 acute care providers in Texas.
Other acute care in El Paso
- Laura WilsonEl Paso$32K
- Ahtesham AliEl Paso$14K
- Adriana SanchezEl Paso$11K
- Haydee BirkhimerEl Paso$10K
- Patricia DandEl Paso$9K
- Dora CarcobaEl Paso$8K
- Jennifer PilotteDallas$232K
- Christie MorrisonSan Antonio$225K
- Amanda BradleyDallas$85K
- Kim HuynhCypress$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.